Intensity-modulated Radiotherapy Market Outlook:
Intensity-modulated Radiotherapy Market size was over USD 2.4 billion in 2025 and is projected to reach USD 3.98 billion by 2035, growing at around 5.2% CAGR during the forecast period i.e., between 2026-2035. In the year 2026, the industry size of intensity-modulated radiotherapy is evaluated at USD 2.51 billion.
The primary driver propelling the growth of the market is the alarming surge in cancer incidence globally.As the prevalence of cancer continues to rise, there is an escalating demand for advanced and targeted treatment modalities that can effectively combat the disease while minimizing collateral damage to healthy tissues. Cancer, being a multifaceted and complex ailment, necessitates treatment approaches that are not only potent but also precise. IMRT, with its ability to deliver highly focused and customized radiation doses to specific cancerous cells, has emerged as a pivotal solution in modern oncology. According to a report published by the World Health Organization (WHO), the global cancer burden is anticipated to increase to 29.5 million new cancer cases per year by 2040, showcasing a substantial rise from the 19.3 million new cases reported in 2020.
The rising cancer incidence underscores the critical need for advanced treatment modalities such as IMRT to meet the growing demand for precise and effective cancer care. Intensity-modulated radiotherapy is a well-established and widely used technology in the field of radiation oncology.
Additionally, IMRT is a type of advanced radiation therapy that allows for more precise targeting of cancer cells while minimizing damage to surrounding healthy tissues.
